- Support of mitochondrial function
- Support of cellular energy metabolism
- Reduction of oxidative stress
- Cardiovascular support
- Neurological support
- Investigational anti-age protocols
- Hypersensitivity to elamipretide
- Allergy to any component of the formulation
- Pregnancy and breastfeeding — medical assessment required
- Pediatric use — depending on the specific formulation and indication
What Is SS-31?
SS-31 (Elamipretide) is a synthetic mitochondria-targeted tetrapeptide developed to act on the inner mitochondrial membrane. It interacts with cardiolipin, a structural component of the mitochondrial me...
What Is SS-31?
SS-31 (Elamipretide) is a synthetic mitochondria-targeted tetrapeptide developed to act on the inner mitochondrial membrane. It interacts with cardiolipin, a structural component of the mitochondrial membrane, and is being investigated in the context of supporting mitochondrial function, cellular energy metabolism, and oxidative stress regulation.
Mechanism of Action
Elamipretide selectively accumulates in mitochondria and binds to cardiolipin. Through this interaction, it is being investigated for its potential role in maintaining mitochondrial membrane integrity and processes involved in cellular energy production. Another area of research focuses on its effects on oxidative stress and mitochondrial dysfunction.
Potential Areas of Application
- Support of mitochondrial function
- Support of cellular energy metabolism
- Research into oxidative stress mechanisms
- Cardiovascular research
- Neurological research
- Investigational anti-age protocols
Key Features of SS-31
- Mitochondria-targeted peptide
- Interacts with cardiolipin
- Investigated in the context of mitochondrial dysfunction
- Associated with cellular energy metabolism
- Studied in cardiovascular and neurological research
SS-31 in Current Research
Elamipretide is being studied in areas related to impaired mitochondrial function. Research primarily focuses on its interaction with mitochondrial membranes, cardiolipin, and related cellular metabolic processes. Clinical evidence for specific conditions continues to evolve, so the use of SS-31 beyond approved indications should be considered investigational.
Information
Smart Benefits.
Maximum Impact.
The Science of Longevity in Detail
